Prostate Cancer Clinical Trials in Los Angeles, CA

Prostate Cancer Clinical Trials in Los Angeles, CA

View the best 10 prostate cancer medical studies in Los Angeles, California. Access promising new therapies by applying to a Los Angeles-based Prostate Cancer clinical trial.

Trials in Los Angeles, California

Here are the top 10 medical studies for prostate cancer in Los Angeles, California

Image of The Urology Place in San Antonio, United States.

Vanquish System

Procedure

Recruiting1 award
This trial is testing a device called Vanquish that uses steam to treat prostate cancer. It targets men with a specific type of intermediate-risk prostate cancer. The steam heats up and kills the cancer cells in the prostate.
Image of MD Anderson Cancer Center in Houston, United States.

NX-1607

Chemotherapy

Recruiting1 awardPhase 1
This trial is testing NX-1607, a new experimental drug, in adults with advanced cancers that don't respond to standard treatments. The goal is to see if NX-1607 can safely stop or reduce cancer growth, either by itself or with another drug called paclitaxel. Paclitaxel is a widely used anti-cancer drug for treating various types of solid malignant tumors including breast, ovarian, and lung cancers.
Image of Yale Cancer Center in New Haven, United States.

Radical Prostatectomy +1 More

Procedure

Recruiting1 award6 criteria
This trial compares a new treatment with traditional surgery in men with prostate cancer. The goal is to see if the new treatment can effectively treat cancer while preserving important functions better than surgery. Patients will be followed for several years to assess outcomes. The new treatment is minimally invasive and uses advanced technology to target prostate tissue.
Image of VA Greater Los Angeles Healthcare System in Los Angeles, United States.

18F-Fluciclovine

Recruiting3 awardsPhase 4
This trial will study patients with advanced prostate cancer who are undergoing a specific type of therapy at a VA hospital in Los Angeles. The patients will have several imaging scans before and after the therapy to track the
Image of UCLA in Los Angeles, United States.

PSMA-PET CT

Recruiting1 award
This trial will study if a non-invasive imaging test can detect prostate cancer that would need treatment in men on active surveillance.
Image of NEXT Oncology Virginia in Fairfax, United States.

DCC-3084

MAPK Pathway Inhibitor

Recruiting1 awardPhase 1 & 2
This trial is testing a new drug called DCC-3084 on its own or with other cancer treatments in people with advanced cancers. It will first focus on patients with solid tumors and may include other
Image of Research Site in Lakewood, United States.

Docetaxel +1 More

Taxane

Recruiting1 awardPhase 3
This trial will compare the effect of two different treatments for metastatic prostate cancer. One group will receive a combination of capivasertib and docetaxel, while the other group will receive docetaxel and a placebo. The goal is to see if adding capivasertib to docetaxel improves survival rates.
Image of Tower Urology, in Los Angeles, United States.

Debio 4228

Anti-tumor antibiotic

Recruiting1 awardPhase 2
This trial aims to understand how the drug Debio 4228 moves through and affects the body.
Image of MD Anderson in Houston, United States.

IDE-161

PARP Inhibitor

Recruiting1 awardPhase 1
This trial is testing a new drug called IDE161 to see if it is safe and effective for patients with advanced cancers that have specific genetic changes. The drug works by preventing cancer cells from repairing their DNA, which can lead to their death.
Image of University of Alabama at Birmingham in Birmingham, United States.

Abiraterone

Androgen Deprivation Therapy

Recruiting1 awardPhase 3
This trial is testing whether abemaciclib, when added to abiraterone plus prednisone, can help to treat prostate cancer by prolonging the time before the cancer gets worse.

Phase 3 Trials

Trials With No Placebo

View More Related Trials

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.